Stelerix Web Blog Knowledge at your Fingertips

15Feb/110

KOL Engagement and Alignment.

Here's a quick excerpt from our Special Comprehensive Country Report, India. It's something we've seen addressed again and again in our follow-up interviews.  I've also thrown in a YouTube interview with Tushar Barad who talks about some of the intricacies of engaging with KOLs.

The updated report will be exclusively available for free through our great friends over at pharmaphorum. So you better get registered!

"Respondents identified active engagement of local Key Opinion Leaders as the most effective means to understand their needs. Further, this strategy provides accurate insight into actual affordability as demonstrated by purchasing power and cost of living, in addition to possible commercial strategies and their respective likelihoods. However, our research also suggested that organizations as a whole have been slow to actively engage end-users. Patience and value on the long term was also a key trend among respondents. It was evident from our results that success in India favors ongoing and long-term relationships that grow and evolve over time. While short-term profit can be made, it is clear that the initial time investment and requisite patience were rewarded many times over when focus was placed on the longer term.  A further benefit of continuous investment in “relationship capital” is the evolution of mutually business partnerships. Organizations who establish themselves effectively in India can often leverage their presence to reach other fast-growing markets in the South-Asian and Asia-Pacific region. Our experts agree that to be effective into 2020 and beyond, market leaders must invest proactively in nascent relationships, given the propensity for longer cycle time in such business partnerships. Opportunity to cut costs and drive access will exist for those who look to partner and aid, rather than exploit."

Posted by Jeff

Oh yeah, the full report will also be available for download here, but this week only!!

8Feb/110

Funding Initiatives and Analytical Applications.

As promised, here is the full summary and video transcript of my recent interview with Dr. Gregory Weiss.

Feel free to submit follow-up questions or start a discussion.

If you want to contribute to an upcoming interview or suggest someone as a candidate because of interesting thought-leading work, please contact us or leave a comment here!

Posted by Jeff

28Jan/110

Value-Added Generics

I appreciate your patience in bearing with me in the last few weeks. As you undoubtedly know, I've been busy populating the library section of the main site. I am making a lot of progress, and there is even more in the pipeline.

One of the challenges has been ensuring high-quality audio. Much to my initial dismay, the sound-quality suffered on the first few recordings. For enduring this, I am grateful. After much experimentation I have found a methodology for getting things online relatively quickly and at high-fidelity.

I'm also picking out parts that I thought were of particular value. Here's a clip from Atul Sharma, talking about the importance of innovation in value-added generics.

Posted by Jeff

26Jan/110

Distribution Hurdles.

I caught up with Tushar Barad, Owner of Applied Biosciences, based in Mumbai, to ask him about some of the challenges and successes in his role. I'm editing the interview into bite-size portions, for now. I will compile on a page in the main site, but wanted to publish these wise words as quickly as possible. Here is the first excerpt. I hope you enjoy, as always, please leave your comments.

Posted by Jeff

7Jan/110

NICE Weighs In.

If you haven't noticed, we like interviews. It's an effective way to convey information, because you get to hear the answers from the expert, unfettered. It's doubly exciting then, when the expert-on-trial mentions something independent and confirmatory.

Kalipso Chalkidou, Director of NICE International (National Institute for Clinical Excellence) in the UK, talks about the importance of understanding the sway of public and government payers as stakeholders.

Our favourite part though, is near the end. When she recommends we take time to involve everyone and understand the issues at play. But have a look for yourself:

What do you say?

Posted by Jeff

14Dec/100

Merger Mondays

When you are focused, it is exciting to see dynamic happenings. Here's what I mean:

Today, Lincoln Pharmaceuticals Ltd. further invests in India after initial success in accelerating wound healing. The company sites cost effectiveness and affordability of care as a goal. Interesting.

Watson Pharmaceuticals is also actively looking to get into the India, although plans won't materialize for 18 months.

Reckitt Benckiser will acquire Paras Pharma, and it's diverse array of over the counter consumer products. Analysts noted the price as high, but our own research has continually concluded that a long term outlook and effective logistic and expectation management can lead to very worthwhile ROI.

Posted by Jeff

15Nov/100

Unlocking India – Upcoming Webinar Series

Thanks for stopping by. Here is what we are focusing on, currently. Each blurb is a 2-3 hour webinar. After you read it, can you let us know what specifically you would be most interested in hearing about? Please?

“Mr. Nitin Parab assembles a trio of key opinion leaders for an interactive, case-study driven discussion. Achieve seamless regulatory compliance and ensure accelerated approval and market penetration as Nitin works with leading USFDA and EDQM experts.”

“Dr. Varma is a key player in a wide network of experts, who consistently craft successful contract-manufacturing agreements, and reap the benefits. Partake in an interactive discussion. Overcome common hurdles. Cut costs, drastically. Create effective and scalable strategic alliances with qualified local partners.”

“Hear from the architect of a record global licensing and distribution deal. Mr. Alok Kumar explains how to thrive in a fragmented market, wherein 10,000 companies vie for 70% of market share. He is the undeniable expert, when it comes to implementing immensely profitable alliances.”

“Dr. Anantharaman and three of his leading industry peers will provide an in-depth analysis of what is required for maximum market access. Specific emphasis will be placed on how scientific and evidence-based marketing strategies have been used as a significant driver of market share in a fragmented and tumultuous Indian market”

Thanks for reading. So, what do you think?

Tell us how we can refine this content. What information would make a webinar worth your while? Think about it! We can do this for you!

Answer here.

To request more information about attending these webinars, scalable advertising, or to subscribe to our newsletter, email: info@stelerix.com

Follow: @stelerix